Perspective Therapeutics, Inc. Annual Income Tax Expense (Benefit) in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Perspective Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2014 to 2023.
  • Perspective Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending December 31, 2023 was $7.85M.
  • Perspective Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending December 31, 2023 was -$2.65M.
  • Perspective Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was -$2.65M.
  • Perspective Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
  • Perspective Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$2.65M -$2.65M Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $0 $0 Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $0 $0 Jul 1, 2020 Jun 30, 2021 10-KT 2023-05-01
2020 $0 $0 Jul 1, 2019 Jun 30, 2020 10-KT 2023-05-01
2019 $0 $0 Jul 1, 2018 Jun 30, 2019 10-K 2021-09-27
2018 $0 $0 Jul 1, 2017 Jun 30, 2018 10-K 2020-09-25
2017 $0 $0 Jul 1, 2016 Jun 30, 2017 10-K 2019-09-27
2016 $0 $0 Jul 1, 2015 Jun 30, 2016 10-K 2018-09-26
2015 $0 $0 Jul 1, 2014 Jun 30, 2015 10-K 2017-09-28
2014 $0 Jul 1, 2013 Jun 30, 2014 10-K 2016-09-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.